Andere Sprachen Terumo Corporation OTC Markets

Aktien

A0YHJ7

US88156J1051

TRUMY

Verzögert OTC Markets Andere Börsenplätze 21:16:39 28.06.2024			% 5 Tage	% 1. Jan.
16,44 ^USD	+0,09 %		+2,31 %	+0,55 %

11.06.	Japans Nikkei steigt dank US-Aktien, schwergewichtiger Chip-Aktien	RE
28.05.	Terumo Cardiovascular kündigt 510(K)-Zulassung für das CDI Oneview? Überwachungssystem	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

MicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United States	26.06.
Terumo : Announces Voting Results for the Election of Directors	26.06.
Japan's Nikkei rises on US stocks, heavyweight chip shares	11.06.
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView Monitoring System	29.05.
Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System	28.05.
Terumo : NICE PUBLISHES A GUIDANCE SUPPORTING THE USE OF SELECTIVE INTERNAL RADIATION THERAPY FOR NEUROENDOCRINE TUMORS WITH LIVER METASTATIS	17.05.
Terumo : Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024	16.05.
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note)	15.05.
Correction: Terumo’s Profit Up 47% in Fiscal 2024	15.05.
Terumo’s Profit Up 47% in Fiscal 2023	15.05.
Les actions mèmes rugissent à nouveau	14.05.
Terumo : The Future of Terumo "Our vision and the path to it"	14.05.
Terumo : Financial Results for the Fiscal Year Ended March 31, 2024	14.05.
En Direct des Marchés : Veolia, Stellantis, BNP Paribas, Bayer, Anglo American, Rheinmetall, Uber...	14.05.
Terumo : Appoints the Candidates for Directors	14.05.
Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024; Provides Second Quarter-End and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	14.05.
Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025	14.05.
Penumbra, Inc. : El desvalido de la atención sanitaria	15.04.
Penumbra, Inc. : The underdog in healthcare	12.04.
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	18.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Terumo Corporation OTC Markets

Aktien

A0YHJ7

US88156J1051

TRUMY

Andere Sprachen

Filter